Endo (NDOI) Non Operating Income : $3,622 Mil (TTM As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Endo Non Operating Income?

Non Operating Income is income or expense that comes from miscellaneous sources. Endo's Non Operating Income for the three months ended in Dec. 2024 was $0 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Dec. 2024 was $3,622 Mil.

Endo Non Operating Income Historical Data

The historical data trend for Endo's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo Non Operating Income Chart

Endo Annual Data

Trend

Dec22

Dec23

Dec24

Non Operating Income

-2,859.50

-2,773.84

Endo Quarterly Data
	Jun23	Sep23	Dec23	Apr24	Sep24	Dec24
Non Operating Income	Get a 7-Day Free Trial			-67.91	-2,492.14	6,116.98	-2.53	-

Endo Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $3,622 Mil.

Endo Non Operating Income Related Terms

Thank you for viewing the detailed overview of Endo's Non Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Endo Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo Inc (OTCPK:NDOI) » Definitions » Non Operating Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

9 Great Valley Parkway, Malvern, PA, USA, 19355

Website

https://www.endo.com

Endo Inc is a diversified pharmaceutical company. It has four reportable business segments: (1) Branded Pharmaceuticals, (2) Sterile Injectables, (3) Generic Pharmaceuticals and (4) International Pharmaceuticals. Branded Pharmaceuticals segment includes a variety of branded products in the therapeutic areas of urology, orthopedics, etc. Sterile Injectables segment consists of branded sterile injectable products such as ADRENALIN, VASOSTRICT and APLISOL, among others. Generic Pharmaceuticals segment includes a product portfolio including patches, solid oral extended-release products, etc. Key revenue is generated from International Pharmaceuticals segment includes a variety of specialty pharmaceutical products, including OTC products, sold outside the U.S.